ChemicalBook > CAS DataBase List > Mifamurtide

Mifamurtide

Product Name
Mifamurtide
CAS No.
83461-56-7
Chemical Name
Mifamurtide
Synonyms
MIFAMURTIDE;MTP-PE;CGP 19835;MLV 19835;MTP-cephalin;L-MTP-PE. MTP-PE;CGP 19835A Lipid;Medchemexpress(MTP-PE);Mifamurtide (CGP-19835);muramyl tripeptide phosphatidylethanolamine
CBNumber
CB11249151
Molecular Formula
C59H109N6O19P
Formula Weight
1237.52
MOL File
83461-56-7.mol
More
Less

Mifamurtide Property

Density 
1.152
storage temp. 
-20°C
solubility 
water: soluble2mg/mL, clear (warmed)
form 
powder
pka
1.39±0.50(Predicted)
color 
white to beige
Water Solubility 
water: 2mg/mL, clear (warmed)
InChIKey
ZVLWUMPAHCEZAW-HYGHKABSNA-N
CAS DataBase Reference
83461-56-7
More
Less

Safety

WGK Germany 
3
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

TRC
Product number
M343940
Product name
Mifamurtide
Packaging
25mg
Price
$13390
Updated
2021/12/16
Biosynth Carbosynth
Product number
FM36618
Product name
Mifamurtide
Packaging
0.5mg
Price
$800
Updated
2021/12/16
Biosynth Carbosynth
Product number
FM36618
Product name
Mifamurtide
Packaging
1mg
Price
$1000
Updated
2021/12/16
Biosynth Carbosynth
Product number
FM36618
Product name
Mifamurtide
Packaging
2mg
Price
$1200
Updated
2021/12/16
Biosynth Carbosynth
Product number
FM36618
Product name
Mifamurtide
Packaging
5mg
Price
$1500
Updated
2021/12/16
More
Less

Mifamurtide Chemical Properties,Usage,Production

Uses

Osteosarcoma.

Uses

Mifamurtide may be used in immunological and cancer-related cell signaling studies.

Biochem/physiol Actions

Mifamurtide is an immunomodulator and regulates the activation of monocytes and macrophages. Mifamurtide upregulates the secretion of pro-inflammatory cytokines such as TNF-α, IL-1, IL-8, nitric oxide and prostaglandins E2 and D2. It has anti-tumor effects in children and young adults with high-grade osteosarcoma.

Mechanism of action

Being a phospholipid, mifamurtide accumulates in the lipid bilayer of the liposomes upon infusion. After application of the liposomal infusion, the drug is cleared from the plasma within minutes. However, it is concentrated in lung, liver, spleen, nasopharynx and thyroid, and the terminal half-life is 18 hours, which is longer than the natural substance.

Clinical Use

Mifamurtide is an anticancer agent for the treatment of osteosarcoma, the most common primary malignancy of bone tissue mainly affecting children and adolescents. The drug was invented by Ciba-Geigy (now Novartis) in the early 1980s and the agent was subsequently licensed to Jenner Biotherapies in the 1990s. IDM Pharma bought the rights to the drug from Jenner in April 2003.In March 2009, mifamurtide was approved in the 27 European Union member states plus Iceland, Liechtenstein and Norway via a centralized marketing authorization. After the approval, IDM Pharma was acquired by Takeda, which began launching mifamurtide, as Mepact ®, in February 2010. Mifamurtide, a fully synthetic lipophilic derivative of muramyl dipeptide (MDP), is muramyl tripeptide phosphatidylethanolamine (MTP-PE), which is formulated as a liposomal infusion.

Side effects

Mifamurtide is generally well tolerated; adverse events attributed to its administration include chills, fever, headache, nausea, and myalgias[1].

Synthesis

Two synthetic routes have been reported, and the scheme describes the more process-amenable route. Commercially available 1,2-dipalmitoyl-snglycero- 3-phosphoethanolamine (110) was coupled with N-Boc-L-alanine (111) by means of Nhydroxysuccinimide (112), DCC in DMF to give amide 113, which was followed by hydrogenolysis of the CBZ group to give the corresponding L-alanyl-phosphoric acid 114. Next, commercially available N-acetylmuramoyl-L-alanyl-D-isoglutamine (115) was subjected to hydroxybenzotriazole (HOBT) and DIC in DMF to provide the corresponding succinimide ester 116 which was condensed with compound 114 to provide mifamurtide (IX). No yields were provided for these transformations.

Drug interactions

Potentially hazardous interactions with other drugs
Analgesics: avoid with high dose NSAIDs.
Ciclosporin: avoid concomitant use.
Corticosteroids: avoid concomitant use.
Tacrolimus: avoid concomitant use.

Metabolism

The cells of the reticuloendothelial system clear mifamurtide liposomes by phagocytosis.

References

[1] Frampton, James E. “Mifamurtide: a review of its use in the treatment of osteosarcoma.” Paediatric drugs vol. 12,3 (2010): 141-53. doi:10.2165/11204910-000000000-00000

Mifamurtide Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Mifamurtide Suppliers

LGM Pharma
Tel
1-(800)-881-8210
Fax
615-250-9817
Email
inquiries@lgmpharma.com
Country
United States
ProdList
2123
Advantage
70
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
Creative Peptides
Tel
Email
info@creative-peptides.com
Country
United States
ProdList
6083
Advantage
56
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19552
Advantage
58
MedChemExpress
Tel
--
Fax
--
Email
sales@medchemexpress.com
Country
United States
ProdList
6398
Advantage
58
Riedel-de Haen AG
Tel
--
Fax
--
Country
United States
ProdList
6773
Advantage
87
Alfa Chemistry
Tel
--
Fax
--
Email
info@Alfa-Chemistry.com
Country
United States
ProdList
6814
Advantage
0
HONEST JOY HOLDINGS LIMITED
Tel
--
Fax
--
Email
sales@honestjoy.cn
Country
United States
ProdList
6675
Advantage
54
More
Less

View Lastest Price from Mifamurtide manufacturers

Shaanxi Dideu Medichem Co. Ltd
Product
Mifamurtide 83461-56-7
Price
US $0.10/KG
Min. Order
0.10000000149011612KG
Purity
98%HPLC
Supply Ability
200tons
Release date
2025-09-17
Henan Bao Enluo International TradeCo.,LTD
Product
N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine 83461-56-7
Price
US $45.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
20tons
Release date
2023-05-12
Henan Bao Enluo International TradeCo.,LTD
Product
mifamurtide 83461-56-7
Price
US $45.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
20tons
Release date
2023-05-18

83461-56-7, MifamurtideRelated Search:


  • N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine
  • muramyl tripeptide phosphatidylethanolamine
  • MIFAMURTIDE
  • N-(N-Acetylmuramoyl)-L-alanyl-D-alpha-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-L-alaninamide
  • CGP 19835
  • L-MTP-PE. MTP-PE
  • MLV 19835
  • MTP-PE
  • MTP-cephalin
  • N-(N-Acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-L-alaninamide
  • Mifamurtide (CGP-19835)
  • CGP 19835A Lipid
  • CGP 19835A LIPID;MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE LIPOSOME;L-MTP-PE;CGP-19835;MTP-PE;MTP-CEPHALIN;CGP19835;L-MTP-PE;MLV19835
  • muramyl tripeptide phosphatidylethanolamine liposome
  • L-Alaninamide, N-(N-acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-
  • N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine USP/EP/BP
  • Medchemexpress(MTP-PE)
  • 83461-56-7